In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...
A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.
A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...
The two strategies, used to reduce renal, brain, and heart injury after surgery, were ineffective, but the story isn’t done.